Emerging infections 9 / edited by W. Michael Scheld, M. Lindsay Grayson, James M. Hughes.

Contributor(s):

Material type: Text

text

Media type:

computer

Carrier type:

online resource

ISBN:

9781683671251
1683671252
9781555816803
1555816800
1283034395
9781283034395
9786613034397
6613034398

Subject(s): Genre/Form:

Additional physical formats: Print version:: Emerging infections 9.DDC classification:

616.9 23

LOC classification:

RA643 .E44 2010eb

NLM classification:

Online Book

Online resources:

Click here to access online

Contents:

Contributors; Foreword; Preface; Acknowledgments; 1. Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia; 2. Reemergence of Human Adenovirus 14; 3. Is Acanthamoeba polyphaga Mimivirus an Emerging Causative Agent of Pneumonia?; 4. The Global Impact of Hepatitis E: New Horizons for an Emerging Virus; 5. New Lymphocytic Choriomeningitis Virus-Like Arenavirus Infections; 6. Human T-Lymphotropic Virus 1: Clinical Aspects of a Neglected Infection among Indigenous Populations; 7. Cytomegalovirus Infection in Transplantation.

Summary: Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America have organized sessions on current and emerging infectious disease threats during their annual meetings. Chapters in Emerging Infections 9 are based on recent sessions, focusing on a broad range of infectious agents that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

Print version record.

Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America have organized sessions on current and emerging infectious disease threats during their annual meetings. Chapters in Emerging Infections 9 are based on recent sessions, focusing on a broad range of infectious agents that pose challenges for the clinical, laboratory, research, public health, and animal health communities.